Microfluidic Thrombosis under Multiple Shear Rates and Antiplatelet Therapy Doses

The mainstay of treatment for thrombosis, the formation of occlusive platelet aggregates that often lead to heart attack and stroke, is antiplatelet therapy. Antiplatelet therapy dosing and resistance are poorly understood, leading to potential incorrect and ineffective dosing. Shear rate is also suspected to play a major role in thrombosis, but instrumentation to measure its influence has been limited by flow conditions, agonist use, and non-systematic and/or non-quantitative studies. In this work we measured occlusion times and thrombus detachment for a range of initial shear rates (500, 1500, 4000, and 10000 s−1) and therapy concentrations (0–2.4 µM for eptifibatide, 0–2 mM for acetyl-salicylic acid (ASA), 3.5–40 Units/L for heparin) using a microfluidic device. We also measured complete blood counts (CBC) and platelet activity using whole blood impedance aggregometry. Effects of shear rate and dose were analyzed using general linear models, logistic regressions, and Cox proportional hazards models. Shear rates have significant effects on thrombosis/dose-response curves for all tested therapies. ASA has little effect on high shear occlusion times, even at very high doses (up to 20 times the recommended dose). Under ASA therapy, thrombi formed at high shear rates were 4 times more prone to detachment compared to those formed under control conditions. Eptifibatide reduced occlusion when controlling for shear rate and its efficacy increased with dose concentration. In contrast, the hazard of occlusion from ASA was several orders of magnitude higher than that of eptifibatide. Our results show similar dose efficacy to our low shear measurements using whole blood aggregometry. This quantitative and statistically validated study of the effects of a wide range of shear rate and antiplatelet therapy doses on occlusive thrombosis contributes to more accurate understanding of thrombosis and to models for optimizing patient treatment.

[1]  R. Califf,et al.  Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.

[2]  E. Braunwald,et al.  Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy , 2000, Circulation.

[3]  C. Hofer,et al.  Perioperative assessment of platelet function in patients under antiplatelet therapy , 2010, Expert review of medical devices.

[4]  S. Jackson,et al.  Dynamics of platelet thrombus formation , 2009, Journal of thrombosis and haemostasis : JTH.

[5]  G. Hankey,et al.  Aspirin resistance: a new independent predictor of vascular events? , 2003, Journal of the American College of Cardiology.

[6]  J. Vane,et al.  The mechanism of action of aspirin. , 2003, Thrombosis research.

[7]  Scott L Diamond,et al.  A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing blood. , 2008, Lab on a chip.

[8]  V. Knappertz,et al.  Aspirin and clopidogrel resistance: an emerging clinical entity. , 2006, European heart journal.

[9]  Andrew T. Irish,et al.  Sources of Variability in Platelet Accumulation on Type 1 Fibrillar Collagen in Microfluidic Flow Assays , 2013, PloS one.

[10]  J. Moake,et al.  Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. , 1995, Circulation.

[11]  Luke P. Lee,et al.  Stand-alone self-powered integrated microfluidic blood analysis system (SIMBAS). , 2011, Lab on a chip.

[12]  A. Maree,et al.  Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease , 2007, Circulation.

[13]  M. Matthay,et al.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. , 2009, The Journal of clinical investigation.

[14]  Shaun P Jackson,et al.  The growing complexity of platelet aggregation. , 2007, Blood.

[15]  D. Ku,et al.  Rapid Platelet Accumulation Leading to Thrombotic Occlusion , 2011, Annals of Biomedical Engineering.

[16]  J. Antaki,et al.  Investigation of platelet margination phenomena at elevated shear stress. , 2007, Biorheology.

[17]  S. Jackson,et al.  Signaling events underlying thrombus formation , 2003, Journal of thrombosis and haemostasis : JTH.

[18]  L. Basabe‐Desmonts,et al.  Assaying the efficacy of dual-antiplatelet therapy: use of a controlled-shear-rate microfluidic device with a well-defined collagen surface to track dynamic platelet adhesion , 2013, Analytical and Bioanalytical Chemistry.

[19]  I. Maruyama,et al.  A novel automated microchip flow‐chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions , 2011, Journal of thrombosis and haemostasis : JTH.

[20]  T. Grosser,et al.  Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin , 2013, Circulation.

[21]  R. Wilcox,et al.  Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. , 1998, Circulation.

[22]  I. Maruyama,et al.  A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process. , 2012, Microvascular research.

[23]  G. Dangas,et al.  Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents , 2011, Circulation.

[24]  Arnan Mitchell,et al.  A microfluidics device to monitor platelet aggregation dynamics in response to strain rate micro-gradients in flowing blood. , 2010, Lab on a chip.

[25]  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. , 1998, The New England journal of medicine.

[26]  G. Tjønnfjord,et al.  Reduced Effect of Aspirin on Thrombus Formation at High Shear and Disturbed Laminar Blood Flow , 1996, Thrombosis and Haemostasis.

[27]  M. Li,et al.  Different effects of various anti‐GPIIb‐IIIa agents on shear‐induced platelet activation and expression of procoagulant activity , 2003, Journal of thrombosis and haemostasis : JTH.

[28]  C. Lodigiani,et al.  Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood , 2011, Journal of thrombosis and haemostasis : JTH.

[29]  P. Kierulf,et al.  Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  F. Neumann,et al.  Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting. , 2001, Journal of the American College of Cardiology.

[31]  N. Schork,et al.  Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. , 2011, JAMA.

[32]  J. Moake,et al.  In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. , 2012, The Journal of clinical investigation.

[33]  J. Zwaginga,et al.  Flow‐based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future 1 , 2006, Journal of thrombosis and haemostasis : JTH.

[34]  S. Hanson,et al.  Blood flow and antithrombotic drug effects. , 1998, American heart journal.

[35]  J. Turgeon,et al.  A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. , 2007, European heart journal.

[36]  E. Vicaut,et al.  Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study. , 2004, Journal of the American College of Cardiology.

[37]  Scott L. Diamond,et al.  Thrombus Growth and Embolism on Tissue Factor-Bearing Collagen Surfaces Under Flow: Role of Thrombin With and Without Fibrin , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[38]  J. Hirsh,et al.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[39]  Angela A. Sodemann.  Micromilling of molds for microfluidic blood diagnostic devices , 2009 .

[40]  A. Groisman,et al.  Microfluidic devices for studies of shear-dependent platelet adhesion. , 2008, Lab on a chip.

[41]  D. Ku,et al.  MICROFLUIDIC SYSTEM FOR MULTICHANNEL OPTICAL MEASUREMENT OF SHEAR-INDUCED PLATELET THROMBOSIS IN UNFRACTIONATED BLOOD , 2011 .

[42]  V. Deneer,et al.  Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. , 2010, JAMA.

[43]  K. Sakariassen,et al.  A perfusion chamber developed to investigate thrombus formation and shear profiles in flowing native human blood at the apex of well-defined stenoses. , 1994, Arteriosclerosis and Thrombosis A Journal of Vascular Biology.

[44]  E. Topol,et al.  A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. , 2003, Journal of the American College of Cardiology.

[45]  D. Ku,et al.  Fluid mechanics of vascular systems, diseases, and thrombosis. , 1999, Annual review of biomedical engineering.

[46]  G. Lip,et al.  The role of aspirin in cardiovascular prevention: implications of aspirin resistance. , 2008, Journal of the American College of Cardiology.

[47]  S. Diamond,et al.  Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear‐resistance of platelet aggregates , 2008, Journal of thrombosis and haemostasis : JTH.

[48]  U. Losert,et al.  Variable Platelet Response to Low-dose ASA and the Risk of Limb Deterioration in Patients Submitted to Peripheral Arterial Angioplasty , 1997, Thrombosis and Haemostasis.

[49]  C. Werter,et al.  Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. , 1993, Journal of the American College of Cardiology.

[50]  K. Kottke-Marchant,et al.  State-of-the-Art Review : The Effect of Antiplatelet Drugs, Heparin, and Preanalytical Variables on Platelet Function Detected by the Platelet Function Analyzer (PFA-100®) , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[51]  G. Palomaki,et al.  Sources of Variability , 2009 .

[52]  J. Sixma,et al.  Functional self-association of von Willebrand factor during platelet adhesion under flow , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Arnan Mitchell,et al.  A shear gradient–dependent platelet aggregation mechanism drives thrombus formation , 2009, Nature Medicine.

[54]  S. Diamond,et al.  Microfluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirin. , 2013, Clinical chemistry.

[55]  A. Bernardo,et al.  Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen‐induced platelet aggregation , 2004, Journal of thrombosis and haemostasis : JTH.

[56]  A. Michelson.  Platelet function testing in cardiovascular diseases. , 2004, Circulation.

[57]  Carolyn G. Conant,et al.  Platelet adhesion and aggregation under flow using microfluidic flow cells. , 2009, Journal of visualized experiments : JoVE.

[58]  Craig R Forest,et al.  Microfluidic system for simultaneous optical measurement of platelet aggregation at multiple shear rates in whole blood. , 2012, Lab on a chip.

[59]  Tae Joon Seok,et al.  Microenvironmental Geometry Guides Platelet Adhesion and Spreading: A Quantitative Analysis at the Single Cell Level , 2011, PloS one.